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Abstract
Background: Electronic health record (EHR) systems generate large datasets that can significantly enrich the development of
medical predictive models. Several attempts have been made to investigate the effect of glycated hemoglobin (HbA1c) elevation
on the prediction of diabetes onset. However, there is still a need for validation of these models using EHR data collected from
different populations.
Objective: The aim of this study is to perform a replication study to validate, evaluate, and identify the strengths and weaknesses
of replicating a predictive model that employed multiple logistic regression with EHR data to forecast the levels of HbA1c. The
original study used data from a population in the United States and this differentiated replication used a population in Saudi
Arabia.
Methods: A total of 3 models were developed and compared with the model created in the original study. The models were
trained and tested using a larger dataset from Saudi Arabia with 36,378 records. The 10-fold cross-validation approach was used
for measuring the performance of the models.
Results: Applying the method employed in the original study achieved an accuracy of 74% to 75% when using the dataset
collected from Saudi Arabia, compared with 77% obtained from using the population from the United States. The results also
show a different ranking of importance for the predictors between the original study and the replication. The order of importance
for the predictors with our population, from the most to the least importance, is age, random blood sugar, estimated glomerular
filtration rate, total cholesterol, non–high-density lipoprotein, and body mass index.
Conclusions: This replication study shows that direct use of the models (calculators) created using multiple logistic regression
to predict the level of HbA1c may not be appropriate for all populations. This study reveals that the weighting of the predictors
needs to be calibrated to the population used. However, the study does confirm that replicating the original study using a different
population can help with predicting the levels of HbA1c by using the predictors that are routinely collected and stored in hospital
EHR systems.
(JMIR Med Inform 2020;8(7):e18963) doi: 10.2196/18963
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Introduction
Diabetes is a growing medical condition worldwide. Globally,
the estimated number of diabetic patients in 2017 was 425
million, and it is expected to be more than 629 million by 2045,
an increase of more than 48%. The number of people with
borderline diabetes is also rapidly increasing. According to the
International Diabetes Federation (IDF), there are 352 million
people worldwide who are at risk of developing diabetes [1].
The latest estimates indicate that 35.3% of the adults in the
United Kingdom and the United States have prediabetes [2].
Type 2 diabetes mellitus (T2DM) is the most common form of
diabetes, accounting for 91% to 95% of all cases [3]. T2DM is
difficult to diagnose in its early stages because it does not have
clear clinical symptoms. As a result of the slow development
of its symptoms, it often stays undetected for a long time [4].
The IDF estimates that half of people with diabetes do not know
or feel that they are developing diabetes [1].
Hemoglobin is responsible for transporting oxygen throughout
the body’s cells and, when joined with the glucose within the
blood, it forms glycated hemoglobin (HbA1c) [5,6]. The
International Expert Committee, with members from the
American Diabetes Association (ADA), the European
Association for the Study of Diabetes, and the International
Diabetes Federation [7,8], recommends the use of the glycated
hemoglobin test to identify adults with a high risk of diabetes
[9].
An elevation of HbA1c level in the blood can be related to
chronic complications and lead to serious health conditions [10].
Patients with HbA1c levels of 5.5% to 6.0% have a substantial
risk of developing diabetes, increased by 25% compared with
patients with HbA1c levels less than 5.5%. Furthermore, patients
with HbA1c levels of more than 6.0% have a 50% chance of
developing T2DM over the next 5 years. Those patients are at
20 or more times higher risk than patients who have a level of
5.0% or less [11].
A study by Huang et al [12] showed that patients with HbA1c
levels of 5.7% to 6.5% are likely to develop diabetes in 2.49
years. Not only that, but the trend of the HbA1c test has been
shown to be an important factor for predicting mortality for
patients with T2DM [13]. Furthermore, nondiabetic people with
an elevated HbA1c level have an increased risk of cardiovascular
disease [9,14]. Hence, studies suggest that patients with and
without diabetes with raised levels of HbA1c should be clinically
checked and monitored as a preventive intervention to avoid
developing T2DM or cardiovascular diseases [14,15].
Many studies have investigated the correlation between HbA1c
and clinical variables using statistical and mathematical
approaches [16-19]. However, we are not aware of any that
have performed replications of the predictive models on different
populations. In this paper, we investigate building statistical
models that predict the probability of patients having an elevated
level of HbA1c. We employ comparative statistical models
similar to the models used by Wells et al [2] and apply them to
a larger electronic health record (EHR) dataset collected from
King Abdullah International Medical Research Center
(KAIMRC) [20,21] in Saudi Arabia.
The work by Wells et al [2], which we refer to in this paper as
the original study, focused on predicting the level of HbA1c for
patients who were not previously diagnosed with diabetes or
taking diabetes medications. The data were extracted from the
EHR database of Wake Forest Baptist Medical Center in the
United States. The authors applied a multiple logistic regression
model to create a mathematical equation for calculating the
level of HbA1c (≥5.7). The predictors used in the equation were
chosen from a list of theoretically associated hyperglycemia
variables (laboratory measurements, medication categories,
diagnosis, vital signs, demographics, family history, and social
history variables). After reducing the model’s variables using
Harrell’s model approximation method [22] and removing
variables that caused collinearity, the final equation associated
8 independent variables with the result of the HbA1c blood test.
Restricted cubic splines (RCS) with 3 knots were used for fitting
the continuous predictors into the model [2]. The calculator
achieved an accuracy of 77%.
The independent replication of empirical studies is widely
regarded as being an essential underpinning of the scientific
paradigm. Successful replication of a study by other researchers
is considered to be an important step in verifying the original
findings and helping to determine how widely they apply.
While the vocabulary associated with replication varies across
disciplines [23], the terms employed by Lindsay and Ehrenberg
[24] appear to be widely used and recognized, so they will be
used in this paper. Lindsay and Ehrenberg categorize replication
studies as either (1) close replications or (2) differentiated
replications.
First, a close replication seeks to repeat the original study in a
way that keeps all the “known conditions of the study the same
or very similar” [24]. Hence, such a study employs the same
forms of measurement, sampling, and analysis as the original,
while also seeking to keep the profile of any set of participants
as close to the original as possible. A close replication aims to
test the hypothesis that, when a given study is repeated under
the same experimental conditions as the original study, it should
produce the same (or nearly the same) result.
Second, a differentiated replication introduces known variations
into what Lindsay and Ehrenberg term “fairly major aspects of
the conditions of the study” [24]. Differentiated replications
provide a test of how widely the original findings can be
generalized, their scope, and the conditions under which they
may not hold. For a differentiated replication, therefore, it is
expected that some changes in the outcomes are likely to arise,
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and the question of interest is to what extent and in what form
these outcome changes occur.
In an ideal situation, one or more close replications would be
used to validate the findings of an original study, followed by
a set of differentiated replications used to scope out the extent
of their validity by varying different conditions.
For any replication study, it is possible to vary one or more
factors from those factors that characterize the way that the
study was performed. These may include the team performing
the replication, the analysis process, the type of data employed,
and the population from which the data were derived. As this
study involves analyzing data collected from a human population
rather than conducting an experiment or trial, we can expect
that using a different team to perform a replication should have
no effect. Hence, for a close replication it would be appropriate
to use the same analysis tool with EHRs of the same form as
used in the original study, but pertaining to a different sample
of participants drawn from the same general population used
in the original study.
For the differentiated replication reported here, we have used
the same form of analysis, but have applied this to a set of EHRs
that were derived from a different population. The differences
between the forms of the EHRs constituted one difference, but
these differences were relatively small. The main difference in
the studies arose from the population used. As with the original
study, the selection of participants was largely driven by
availability. We therefore expected that it was quite possible
that there would be some differences in the outcomes, and our
main goal was to investigate the extent and form of those
differences.
Methods
Conduct of the Replication Study
The KAIMRC dataset was collected by the Ministry of National
Guard Health Affairs from the EHR systems of National Guard
Hospitals in Saudi Arabia for the period from 2016 to the end
of 2018. The dataset was then labelled according to the ADA
guidelines. Patients with an HbA1c level of 5.7% or more are
considered to have an elevated HbA1c and those with lower
levels than that are considered normal. The predictors that were
selected by the authors of the original study for calculating the
level of HbA1c, listed in Table 1, were employed in this study,
except for race and smoking status. Taking into account that
most of the data samples in the KAIMRC dataset are from the
same race, the race variable can be omitted, as it has zero
variance [25]. Smoking status information is absent from the
KAIMRC dataset. However, in the original model used by Wells
et al, this was ranked as having the lowest importance of all the
predictors. The BMI and non–high-density lipoprotein measures
were also absent. However, both can be calculated by using the
formulae presented in Multimedia Appendix 1.
Table 1. Predictors available in the original study versus King Abdullah International Medical Research Center datasets.
KAIMRCa datasetOriginal study datasetPredictors
√√Age
√ (calculated)√Body mass index
√√Estimated glomerular filtration rate
√√Random blood sugar (glucose) level




aKAIMRC: King Abdullah International Medical Research Center, Saudi Arabia.
In this study we followed the same sampling approach used in
original study. For inpatient visits, only the first day’s data were
considered, and in cases of missing values, the first available
values for the visit were used. Samples for patients with values
of <1% for HbA1c were simply considered to be erroneous
readings and were excluded. Similar to the original study,
patients diagnosed with diabetes were eliminated from the
development dataset (refer to Multimedia Appendix 2 for
diabetes diagnostic codes). We avoided intensive interpretation
for handling the missing values. Samples with one or more
completely missing values were also excluded. This resulted in
decreasing the dataset size from the 262,559 samples originally
collected to 36,378 samples. Figure 1 shows the detailed
preprocessing tasks performed prior to building the statistical
models.
The descriptive statistics for the KAIMRC experimental dataset
and the dataset used by Wells et al are shown in Table 2. The
units used for recording lab tests can differ according to the
laboratory guidelines followed by each country. The KAIMRC
dataset uses different units than the ones used in the original
study for some variables. For instance, the total cholesterol level
is measured in milligrams per deciliter (mg/dL) in the original
study’s dataset, and in millimoles per liter (mmol/L) in the
dataset from the KAIMRC labs. Therefore, the descriptive
statistics contain the values using both units. When developing
the predictive models, the authors converted the units using the
appropriate formulae (see Multimedia Appendix 3). However,
the conversion task can be avoided to reduce data preprocessing
complexity, as it should not affect the prediction performance
for the logistic regression models.
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Figure 1. Dataset preprocessing details. HbA1c: glycated hemoglobin.
Table 2. Descriptive statistics for King Abdullah International Medical Research Center and original study datasets.










54.8 (14.0)48.1 (15.4)<.00160.5 (14.13)45.5 (17.01)Age (years), mean (SD)
33.0 (8.41)30.1 (7.44)<.00131.50 (12.13)29.61 (10.74)BMI (kg/m2), mean (SD)
87.9 (30.8)92.0 (33.0)<.00182.02 (28.86)93.40 (35.19)eGFRe (mL/min/1.73 m2), mean (SD)
<.001RBSf
5.3 (0.9)4.9 (0.7)8.30 (4.30)5.47 (1.28)RBS (mmol/L), mean (SD)
96.1 (16.0)88.4 (12.7)149.4 (77.47)98.5 (23.00)RBS (mg/dL), mean (SD)
<.001Cholesterol
4.96 (1.11)4.80 (1.01)4.17 (1.16)4.59 (1.19)Cholesterol (mmol/L), mean (SD)
192 (43.1)186 (39.4)161.25 (44.85)177.49 (46.01)Cholesterol (mg/dL), mean (SD)
<.001Non-HDLg
3.72 (1.07)3.49 (0.96)2.49 (0.99)2.85 (1.06)Non-HDL (mmol/L), mean (SD)
144 (41.7)135 (37.4)96.28 (38.28)110.2 (40.99)Non-HDL (mg/dL), mean (SD)
aRefer to Multimedia Appendix 3 for unit conversion formulae.
bKAIMRC: King Abdullah International Medical Research Center, Saudi Arabia.
cWake Forest Baptist Medical Center, North Carolina, United States.
dHbA1c: glycated hemoglobin.
eeGFR: estimated glomerular filtration rate.
fRBS: random blood sugar.
gHDL: high-density lipoproteins.
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A complete validation of Wells et al’s calculator using our
dataset was not possible due to the absence of the smoking status
variable. To validate the approach used in the original study, 3
predictive models (PMs) were built, trained, and tested using
the KAIMRC dataset. All models employ multiple logistic
regression to create the calculator by associating the chosen and
available predictors. After discussion with the authors of the
original study, we structured the models as PM1, PM2, and
PM3.
PM1 was designed to be as close as possible to the original
study’s model. It uses the predictors chosen in the original study:
age, BMI, random blood sugar (RBS), non–high-density
lipoprotein (non-HDL), cholesterol, and estimated glomerular
filtration rate (eGFR). The continuous predictors are fitted to
the model using RCS with 3 knots.
PM2 was designed using the same predictors used in PM1 but
without RCS fitting.
PM3 was designed after excluding the predictors with the least
importance in PM1 and PM2, using a reduced number of
predictors and fitted using RCS with 5 knots. The choice of the
number of knots for this model was determined by using Stone’s
recommendation [26].
The 3 models were validated using the 10-fold cross-validation
approach. The measure used to evaluate and compare the results
with the original study was the concordance statistic, which is
equal to area under the receiver operating characteristic (AUR
ROC) curve [27]. To assist with future comparisons, we report
measures commonly used for medical research, such as
precision, recall, and F1, in the model evaluation. The data
preparations are undertaken using Python (version 3.7; Python
Software Foundation). The model building and the analysis are
carried out in R (version 3.6.0; The R Foundation) using the
regression modeling strategies package.
Results
The development data subset size used for training, testing, and
validating the models after data preprocessing was 36,378
samples. Most medical datasets are imbalanced with a majority
normal population [28], but 60.60% (22,046/36,378) of
KAIMRC dataset patients were found to have elevated levels
of HbA1c (≥5.7%), and 39.40% (14,332/36,378) of patients had
a normal HbA1c level (<5.7%).
Details of the 3 models (PM1, PM2, and PM3) used for the
purpose of validating and evaluating the original study are
shown in Table 3. This study explores multiple logistic
regression models using different numbers of variables, with
and without RCS, and with different numbers of knots. PM1
(using a complete set of variables fitted using RCS) achieves
an average accuracy of 73.67% and 95% CI of 74% to 77%
with a well-calibrated curve. A similar model (PM2), but not
fitted using RCS, shows improved accuracy, with an average
accuracy of 74.04% and the same 95% CI of 74% to 77%.
However, the calibration curve shows better calibration when
applying RCS into the models, as shown in Figures 2 and 3.
Table 3. Performance of models for glycated hemoglobin elevation prediction.




aRCS: restricted cubic splines.
bAUR ROC: area under the receiver operating characteristic.
cPM: predictive model.
dAll variables (age, random blood sugar, cholesterol, non–high-density lipoproteins, estimated glomerular filtration rate, and BMI).
eN/A: not applicable.
fReduced variables (age, random blood sugar, cholesterol, non–high-density lipoproteins, and estimated glomerular filtration rate).
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Figure 2. The calibration curve for PM1. HbA1c: glycated hemoglobin. PM: predictive model.
Figure 3. The calibration curve for PM2. HbA1c: glycated hemoglobin. PM: predictive model.
Figure 4 shows the ranking of importance for the variables used
in the PM1 model. PM1 shows a different order of importance
for the predictors than the order obtained from the original study.
Age and RBS are of great importance in both studies. However,
BMI is of the lowest importance when using the KAIMRC
population, whereas in the original study it was ranked second.
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Figure 4. Order of importance of predictors for PM1. Chol: cholesterol. eGFR: estimated glomerular filtration rate. HDL: high-density lipoproteins.
PM: predictive model. RBS: random blood sugar.
The PM3 model excludes the variable that showed the lowest
importance, BMI. This model, when fitted using RCS with 5
knots, shows better performance using only the 5 predictors
(age, RBS, cholesterol, eGFR, and non-HDL). The eGFR shows
greater importance when fitted using RCS with 5 knots (>0.05)
than when fitted with 3 knots (<0.05). The predictors’
importance order for PM3 is shown in Figure 5. PM3 achieves
an average accuracy of 74.73%, with a better confidence interval
(95% CI 75%-78%). The calibration curve for PM3 is identical
to that of PM1.
Figure 5. Order of importance of predictors for PM3. Chol: cholesterol. eGFR: estimated glomerular filtration rate. HDL: high-density lipoproteins.
PM: predictive model. RBS: random blood sugar.
When using the PM2 model, the results show agreement with
the results from PM1 for 93.27% (33,929/36,378) of predictions.
The PM3 model with fewer predictors achieves a better
performance and a similar percentage of predictions that are in
agreement with the output from PM1 (33,937/36,378, 93.29%).
Furthermore, the results show a strong degree of correlation




Applying the method employed in the original study achieved
an accuracy of 73% to 74% using a dataset collected from the
Middle East, compared with 77% obtained from using a
population from the United States in the original study. The
findings from this replication study therefore confirm the
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conclusion from the original study that this form of modeling
can help with predicting the levels of HbA1c in a blood test for
nondiabetic patients using predictors extracted from EHR
systems.
The order of importance obtained for the predictors used by the
multiple logistic regression on our dataset is different from the
order of importance produced in the original study. The order
for the predictors using the KAIMRC dataset, from the most to
the least importance, is RBS, age, eGFR, cholesterol, non-HDL,
and BMI. Table 4 shows the importance rankings for the
predictors obtained from the original study, as well as the
rankings obtained from the 3 models used in this study.







aRBS: random blood sugar.
bHDL: high-density lipoproteins.
ceGFR: estimated glomerular filtration rate.
dPM: predictive model.
eN/A: not applicable.
BMI was one of the most important predictors in the population
from the United States and demonstrated higher impact than
the RBS and eGFR. However, it shows little importance for
predicting the elevation level of HbA1c in the KAIMRC
population. Indeed, the simpler calculator with a reduced number
of variables (after excluding BMI) is able to achieve better
prediction abilities (refer to Multimedia Appendix 4 for details
of the calculator). Figure 6 summarizes the 10-folds performance
achieved using the reported measures for all models, and reveals
that there is a consistent prediction trend for PM3, especially
in the AUR ROC, which shows little variation between the
folds.
Figure 6. Box plots of the reported measures for the models. AUC ROC: area under the receiver operating characteristic. PM: predictive model.
This replication study shows that the ranking of the variables
is largely based on the dataset and the model used for prediction.
Variables with low importance in the prediction of HbA1c in
one population may show greater or lesser importance when
the model is applied on populations from different regions of
the world. Interestingly, this can also happen when employing
different predictive models and with different hyperparameters
using the same population (for instance, eGFR shows higher
importance when fitted to the model using RCS with 5 knots
in PM3 than with 3 knots in PM1 and without RCS in PM2, as
interpreted in Table 4).
Limitations and Future Work
We performed a differentiated replication using a population
from a different region that was available to us. The 2 datasets
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have similar means and standard deviations for most of the
variables, such as age, cholesterol, and non-HDL, as described
in Table 2. However, there is a significant difference in the body
mass index and random blood sugar variables, and the dispersion
is large for both variables.
The sample size and class balance affect the learning behavior
of the models [29]. The KAIMRC dataset is larger than the one
used in the original study by 38%. The class balance is also
different, with 26% of patients having elevated HbA1c (≥5.7%)
and 74% with normal HbA1c (<5.7%) in the original study
compared with 60.60% (22,046/36,378) with elevated HbA1c
(≥5.7%) and 39.40% (14,332/36,378) with normal HbA1c (<5.7)
in KAIMRC dataset.
Although the population represented in this study is less
heterogeneous with regard to ethic groups, the size of the
KAIMRC dataset is larger than the one used in the original
study. The prevalence of diabetes is also larger, being a sample
from the population of Saudi Arabia. In terms of prevalence of
diabetes, Saudi Arabia was ranked by the World Health
Organization as being the second highest in the Middle East
and seventh highest in the world [30], with an 18.3% diabetes
prevalence rate, according to the IDF, compared with 10.5% in
the United States [31].
In the original study, the model performance was compared
with the models developed by Baan et al [32] and Griffin et al
[33], which used different datasets [34,35]. The main limitation
in the comparison between the original study and the studies
by Baan et al and Griffin et al is the absence of some variables
that were used to create the calculators (refer to Multimedia
Appendix 5 for details about the variables used in the
corresponding studies). The same situation applies to this study,
as the smoking status variable is missing in the KAIMRC
dataset. The smoking prevalence in Saudi Arabia is between
2.4% to 52.3% among different age groups [36]. However, other
missing predictors, such as genetic or lifestyle characteristics
[37], which are difficult to collect and incorporate into the EHR
systems, may help to explain the high rate of elevated levels of
HbA1c in the KAIMRC population.
After eliminating the variables that do not show significant
impact on the prediction of HbA1c in the KAIMRC population,
the results indicate that different regions in the world can have
different weightings of predictors for HbA1c when using the
approach of Wells et al. Although there are many studies that
have demonstrated the relationship between diabetes prevalence
and BMI [38], some studies have shown that the obesity
prevalence in Asian countries does not relate to the diabetes
prevalence. The risk of diabetes occurs in patients with a lower
BMI in Asian countries compared with patients from European
countries [39]. The prevalence of obesity in Asian countries is
substantially less than in the United States, but Asian countries
have a similar or higher prevalence of diabetes [40]. However,
neither Yoon et al [39] nor Hu [40] identifies a relationship
between nondiabetic patients with elevated levels of HbA1c and
obesity. Figure 7 visualizes the class distribution for the BMI
variable for the KAIMRC dataset. The figure shows that
elevation of HbA1c exists with similar rates between low and
high obesity ranges.
Figure 7. HbA1c elevation for BMI ranges of King Abdullah International Medical Research Center patients. HbA1c: glycated hemoglobin.
Advanced data mining techniques, such as deep machine
learning models, are capable of finding hidden and complex
correlations in large input spaces and datasets [41]. Recently,
machine learning models have shown great success in many
domains (eg, natural language processing, image segmentation,
and object detection), but there is still a lack of studies that
apply those models to the medical domain using EHR data [42].
As stated in the original study, maintaining security and privacy
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for medical datasets is a challenging task. However, with
advanced technologies in data privacy and protection, such as
differential privacy and data anonymization techniques [43], it
should be possible to minimize the security risk.
Conclusions
Replication studies provide an invaluable contribution to the
validation, generalization, and continuation of scientific
research. The differentiated replication presented in this study
is aimed at validating the calculator used for predicting HbA1c
and evaluating the method used to create the mathematical
equation by training the multiple logistic regression algorithm
using EHR datasets. The evaluation was performed using a
dataset collected from a different population. The original and
replicated calculators employ associated predictors that are
routinely collected and stored in hospital systems.
As explained in the “Introduction” section, this differentiated
replication study used the same method to analyze a different
population sample, with some differences in the form of the
EHRs. As a replication, it was intended to investigate what
changed and did not change in the outcomes.
What did not change appreciably was the accuracy of the results
produced using this method, with an accuracy range of 73.6%
to 74.7% in our study compared with 77% in the original study.
The set of predictors (when these could be compared) also did
not change. Thus, given that a close replication of the original
study is unavailable, the differentiated replication does confirm
that, despite the notable differences between the two datasets,
the use of multiple logistic regression is able to provide good
predictions of HbA1c elevation levels.
What did change was the order of importance for the set of
predictors used in the calculator. Thus, we can conclude that
the use of multiple logistic regression for prediction does need
to be tuned to the characteristics of the population being
assessed. While we cannot wholly rule out the cause of this
difference in importance being due to differences in the form
of the EHRs, it seems more likely that the characteristics of the
population were an important factor.
In terms of the role of replication itself, we would argue that
this study demonstrates that while there is little difference in
prediction accuracy when using multiple logistic regression
with different populations (as might be expected), the influence
of the different elements in the set of predictors is different.
Due to that, we would argue that the generalization of simple
statistical predictive models (calculators) is inappropriate. We
suggest that creating advanced predictive models that can learn
complex relationships using large multidimensional datasets
may be a better way to exploit the increasing volumes of EHR
data becoming available. Hence, further work will investigate
applying advanced machine learning techniques to predict the
elevation of HbA1c using the KAIMRC dataset.
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AUR ROC: area under the receiver operating characteristic
eGFR: estimated glomerular filtration rate
EHR: electronic health record
HbA1c: glycated hemoglobin
HDL: high-density lipoprotein
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KAIMRC: King Abdullah International Medical Research Center
PM: predictive model
RBS: random blood sugar
RCS: restricted cubic splines
T2DM: type 2 diabetes mellitus
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